Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | TSC-201-B0702 |
| Trade Name | |
| Synonyms | TSC 201-B0702|TSC201-B0702 |
| Drug Descriptions |
Limited information is currently available on TSC-201-B0702, a putative T-cell receptor (TCR) therapy targeting MAGE-C2 presented on HLA-B*07:02 (Jun 2024). |
| DrugClasses | |
| CAS Registry Number | NA |
| NCIT ID | NA |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| TSC-200-A0201 + TSC-201-B0702 | TSC-200-A0201 TSC-201-B0702 | 0 | 1 |
| TSC-201-B0702 | TSC-201-B0702 | 0 | 1 |
| TSC-201-B0702 + TSC-203-A0201 | TSC-201-B0702 TSC-203-A0201 | 0 | 1 |
| TSC-201-B0702 + TSC-204-A0101 | TSC-201-B0702 TSC-204-A0101 | 0 | 1 |
| TSC-201-B0702 + TSC-204-A0201 | TSC-201-B0702 TSC-204-A0201 | 0 | 1 |
| TSC-201-B0702 + TSC-204-C0702 | TSC-201-B0702 TSC-204-C0702 | 0 | 1 |